Newsletter Subject

This Window’s About to Close

From

biotechbreakouts.com

Email Address

kyle@biotechbreakouts.com

Sent On

Wed, Jan 15, 2020 03:42 PM

Email Preheader Text

Hello Undefined, Investing and trading are two different animals. And while most people know me as a

[Kyle's Trades] Hello Undefined, Investing and trading are two different animals. And while most people know me as a trading savant ($7M in career trading profits before the age of 30)... Very few know about my buy and hold long-term portfolio— [Sniper Report](. That’s too bad… considering since the launch of that service nearly two years ago, my last three special reports returned more than 130% in total gains. Incredible when you consider the average hedge fund returned an abysmal 6.9% last year. However, I’m not writing to you today to tell you how great my investing chops are. I have [a brand new special Sniper Report]( coming out this Friday. What can I say, I’m very selective when it comes to my long-term portfolio. There are so many variables to consider when one decides to hold a stock for the long haul. The company not only needs to have strong fundamentals… but it also needs to be in a growth sector… and most importantly it needs to be driven by a catalyst. The last three [special Sniper Report]( alerts delivered on all fronts. - CBD stock XXII went from $1.95 to $2.40 - 5G stock SWKS moved from $93.68 to $124.51 - 5G stock INSG moved from $4.34 to $7.57 However, my next [special Sniper Report](, set to be released this FRIDAY, will likely be my biggest score to date. It’s no surprise that some of Wall Street’s heavy-hitters have already built a substantial stake in this name. I’m talking about the likes of Starboard Value, which has over $5 billion in assets under management…and Hudson Capital Management, which has over $300M invested in the market. Both are proud owners of this stock, which I will reveal to you on Friday, in a [special Sniper Report.]( And while the bankers at Mizuho and UBS have issued a buy rating on this stock… it wasn’t until last week’s 8-K filing to the SEC... I became a BELIEVER. [That’s because we now have a catalyst.]( And in order to participate, you must be a shareholder within the next week. [If you don’t act fast…. You’ll totally miss out.]( For the record… this is NOT - A cannabis company - A 5G multinational - A machine learning enterprise - An artificial intelligence firm - A social networking group - A cloud computing stock [It’s much BIGGER than all of that right now.]( And it’s not some rinky-dink company no one has ever heard of before. One thing I’ve learned from tracking the smart money is that they don’t play guessing games… [When it comes to putting my hard-earned money to work, I don’t either.]( However, due to some unique circumstances – unprecedented, if you ask me – the window for getting in on this trade is closing very soon. [That’s why I’m sending an urgent special Sniper Report this Friday.]( I truly believe the sector this stock is in will be the most talked-about sector in 2020. And my pick, which is set to be released in just a few days, could lead the pack. But I’m afraid that time is of the essence here. And in order to receive my rare special report—[you must be a Sniper Report client.]( Countless traders have already joined the service—[and I want you to join them.]( [Image] [Image] [Image] [Image] This is just the fourth time I’ve issued an urgent report of this nature. [Act now to receive it on Friday](, along with the details on how we’re going to play it. [By this time next week, this opportunity will be gone.]( [Don’t be left behind!]( Cheers to Profits! [Kyle Dennis] [Kyle Dennis] RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Stop receiving exclusive emails from Kyle Dennis]( Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative’s own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com. [Unsubscribe from all RagingBull Emails](

Marketing emails from biotechbreakouts.com

View More
Sent On

31/07/2021

Sent On

31/07/2021

Sent On

17/07/2021

Sent On

09/07/2021

Sent On

08/07/2021

Sent On

08/07/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.